APTUSPHARMA (4)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE announces updated list of securities under Enhanced Surveillance Measure (ESM) framework, including newly shortlisted securities, stage … | |||||||||||||||
BSE announces updated list of securities under Enhanced Surveillance Measure (ESM) framework, including newly shortlisted securities, stage movements, and securities moving out of ESM, effective March 09, 2026. | |||||||||||||||
BSE revises circuit filter to 2% for 68 securities effective from the specified date, implementing tighter price movement restrictions. | |||||||||||||||
BSE revises circuit filter to 2% for 68 securities effective from the specified date, implementing tighter price movement restrictions.
| |||||||||||||||
BSE revises price bands for eight scrips effective January 30, 2026, with bands ranging from 2% to 20%. | |||||||||||||||
BSE revises price bands for eight scrips effective January 30, 2026, with bands ranging from 2% to 20%.
| |||||||||||||||
BSE circular detailing securities moving to higher ESM stages and consolidated list of all securities under Enhanced Surveillance Measure … | |||||||||||||||
BSE circular detailing securities moving to higher ESM stages and consolidated list of all securities under Enhanced Surveillance Measure framework.
| |||||||||||||||